Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment—A Systematic Literature Review

The economic burden of rheumatoid arthritis (RA) on society is high. Disease-modifying antirheumatic drugs (DMARDs) are the cornerstone of therapy. Biological DMARDs are reported to prevent disability and improve quality of life, thus reducing indirect RA costs. We systematically reviewed studies on...

Descripción completa

Detalles Bibliográficos
Autores principales: Batko, Bogdan, Rolska-Wójcik, Paulina, Władysiuk, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721219/
https://www.ncbi.nlm.nih.gov/pubmed/31426543
http://dx.doi.org/10.3390/ijerph16162966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721219/
https://www.ncbi.nlm.nih.gov/pubmed/31426543
http://dx.doi.org/10.3390/ijerph16162966

Ejemplares similares